Why we built an AI research assistant for the private investor who thinks before they act — and what that means in practice.
Private investors have more access to market information than at any point in history. Company filings, sector commentary, earnings transcripts, macroeconomic data — all of it is available, often for free. And yet the quality of investment research among ordinary investors has not improved at the same rate. More information has not automatically produced more clarity. In many cases it has produced more noise, more confirmation bias and more decisions made on incomplete foundations.
The gap that Resquinalen addresses is not a data gap. It is an analytical gap — the distance between having information and knowing what to do with it. That gap is widest when it matters most: when you are forming a view on a company you have not owned before, when a market event challenges your existing thesis, when you need to decide whether a risk is material or manageable. Resquinalen was built to stand in that gap and help you cross it with more rigour than you could bring alone.
Learn More About Resquinalen
Start with whatever is on your mind as an investor — a company you are examining, a sector you want to understand, a decision you are approaching. Resquinalen meets you where you are, whether you have detailed notes already or are starting from scratch. There is no prescribed format: the tool adapts to the shape of your thinking.
Resquinalen helps you structure your research, surface the assumptions embedded in your current thinking, compare scenarios, examine risks and identify the questions that still need answers. It works as a genuine thinking partner — asking the kinds of probing questions that sharpen analysis and flag the gaps that matter most.
The output of a Resquinalen session is not a recommendation. It is a more complete, more honestly examined version of your own research — one that you have tested, questioned and refined. From there, the decision is yours. Resquinalen supports your judgement; it does not substitute for it.
Before adding to a position, you want to know whether your original reasoning still holds. Resquinalen lets you revisit the assumptions you made when you first researched a company — testing whether the growth narrative, the margin expectations and the competitive context have shifted. It surfaces the questions you should be asking rather than confirming the answer you already want to hear. The result is a more disciplined, evidence-aware decision rather than one driven by familiarity or inertia.
Portfolio review scenarioWhen a sector moves sharply on a macro announcement, it can be difficult to separate genuine signal from market noise. Resquinalen helps you examine what the move might mean for specific companies in that sector — mapping the exposure, identifying which businesses are structurally affected and which are caught in broader sentiment. Rather than reacting to a headline, you build a structured picture of what has actually changed and what remains uncertain, giving your response a firmer analytical foundation.
Market signal scenarioComparing two companies in the same sector sounds straightforward until you realise the metrics that matter most are rarely presented in the same way. Resquinalen helps you construct a side-by-side research framework — aligning the variables that are genuinely comparable, flagging where accounting differences or business model distinctions make direct comparison misleading, and helping you articulate what would have to be true for each option to justify its current valuation. The comparison becomes a research exercise rather than a superficial ranking.
Comparative research scenarioResquinalen is an AI research assistant. It is a tool for thinking — for organising research, examining assumptions, mapping scenarios and noticing what you might have missed. It works alongside you as you form your own investment views. It does not form those views for you, and it does not act on them. Resquinalen does not execute trades, does not manage assets and does not provide regulated financial advice. It is a research and analysis platform for private investors who make their own decisions.
This distinction matters because the most valuable thing Resquinalen can do is help you think more clearly — not think on your behalf. An investment view that has been genuinely examined, tested against alternatives and honestly assessed for risk is a fundamentally different thing from a recommendation you have received and acted on. Resquinalen is built on the belief that independent, rigorous thinking produces better long-term outcomes than delegated certainty.
Resquinalen is designed for the ordinary private investor who takes their research seriously. Not a professional fund manager with a team of analysts, and not someone looking for a shortcut to a decision. The target user is someone who reads carefully, thinks in scenarios, wants to understand what they own before they own it and is willing to do the analytical work that good investment research requires. They may be experienced or relatively new to investing — what they share is intellectual seriousness and a preference for evidence over instinct.
If you recognise yourself in that description, Resquinalen is built for you. It will not make investing easy or certain — nothing honest can promise that. But it will make your research more structured, your assumptions more visible and your decisions more genuinely your own. That is the standard we hold ourselves to, and it is the standard we think serious investors deserve from a research tool.